Biotechnology in Brazil

Experts involved in biotechnology often encounter problems that are not their traditional training because many come from basic science such as mathematics, chemistry, biology. In Brazil, few experts deal with engineering, management, legal knowledge and trained biotechnology; they not only need these skills but also need to innovate in this area as well as research there is. Therefore, experts need to master more areas or more easily enter these areas.

This article analyzes the pattern of health biotechnology publications in six countries in Latin America from 2001 to 2015. The countries surveyed were Argentina, Brazil, Chile, Colombia, Cuba, Mexico. Prior to our study, half of the Latin American countries we studied, Argentina, Colombia and Chile had no data on HBT development. By incorporating these countries into the quantitative analysis of HBT, we can obtain a more comprehensive picture of HBT development in Latin America. Scientometrics research uses the Web of Science database to identify healthy biotechnology publications. During the research period, the total world health biotechnology production totaled about 400,000. A total of 1.2% of the papers in this survey was written by six Latin American countries in this survey. Research growth in some countries in Latin America is greater than that of most industrialized countries.

The rise of health biotechnology research in Latin America: scientific analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico

Countries that have promoted biotechnology in the last century have played a leading role in this field. The United States (USA) is the world leader in the field of biotechnology. In 2006, the United States invested $ 22 billion in biotechnology research and development (R & D), investment continued to increase, reaching $ 33.9 billion in 2015. By contrast, the second largest investor in Europe invested $ 3.6 billion in biotechnology in 2006 and invested $ 6.2 billion in 2015 as a whole. At the same time, the US Congress is one of the first meetings to introduce biotechnology policies and laws. Another historical example is the European Union (at the time, the European Community) that allocated more than $ 300 million to the biotechnology-related projects in the early 1980s. These plans are the first steps to create a biotechnology industry in Europe.

The rise of health biotechnology research in Latin America: scientific analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico

Industrial biotechnology (commonly referred to as white biotechnology in Europe) is the application of biotechnology to industrial purposes including industrial fermentation. It involves using cellular components such as microorganisms or enzymatic cells to produce industrially useful products in industries such as chemicals, food and feed, detergents, paper and pulp, textiles and biofuels . Significant progress has been made in the creation of genetically modified organisms (GMOs) that enhance the diversity and economic viability of industrial biotechnology applications over the past several decades. By using renewable raw materials to produce various chemical substances and fuels, industrial biotechnology actively promotes reduction of greenhouse gas emissions and release of petrochemical economy.